Trump Signs Executive Order to Boost US Pharma Supply Chain
US President Donald Trump has instructed the Department of Health and Human Services (HHS) to compile a list of essential medicines and ensure the...
Lupin, Sandoz Collab to Commercialise Biosimilar Ranibizumab
Lupin partners with Sandoz Group AG to commercialise and market its biosimilar ranibizumab worldwide. The product will be commercialised in a number of markets,...
FDA PreCheck Programme to Boost U.S. Drug Manufacturing
The Food and Drug Administration has launched a new initiative aimed at boosting drug manufacturing within the United States. This move follows a directive...
Thermo Fisher New HMW Kit Powers Long-Read DNA Sequencing
Thermo Fisher Scientific has unveiled the Applied Biosystems MagMAX HMW DNA Kit, a new solution that supports both manual and automated workflows to enable...
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
Aptar Pharma, a global leader in drug delivery and active material science solutions and services, announced its acquisition of the clinical trial materials manufacturing...
Thermo Fisher and Sanofi Partners for US Drug Manufacturing
Thermo Fisher Scientific announced an expansion plan with its strategic partnership with Sanofi that will enable additional US drug product manufacturing. The terms of...
Regulatory Trends in Pharma Manufacturing to Watch in 2025
Regulatory Trends in Pharma Manufacturing: Key Changes to Watch in 2025
Pharmaceutical manufacturing is a sector that is highly dynamic, as it is situated at...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...